Israeli duo’s early Alzheimer’s detection test brings cure one step closer

Toronto-based biomedical engineers Eliav Shaked and Roy Kirshon are working on a quick, non-invasive retinal diagnostic for patients decades away from showing symptoms of dementia. As business partners in an artificial intelligence medical imaging start-up called RetiSpec, they’ve developed a new way for early detection of Alzheimer’s disease, the main cause of dementia among older adults.

In 2019, the Ontario Bioscience Innovation Organization chose RetiSpec as one of several high-potential health science companies for its Capital Access Advisory Program.